As p38 kinase inhibitors ω- carboxyaryl substituted diphenyl ureas

2000 
(57) Abstract: The present invention is a use in the treatment of p38 mediated diseases of a group of aryl ureas, to pharmaceutical compositions for use in such therapies.
    • Correction
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []